| Literature DB >> 29268719 |
Kirsten J Coppell1, Sally L Abel2, Trish Freer3, Andrew Gray4, Kiri Sharp5, Joanna K Norton5, Terrie Spedding3, Lillian Ward3, Lisa C Whitehead6.
Abstract
BACKGROUND: Primary care nurse-led prediabetes interventions are seldom reported. We examined the implementation and feasibility of a 6-month multilevel primary care nurse-led prediabetes lifestyle intervention compared with current practice in patients with prediabetes, with weight and glycated haemoglobin (HbA1c) as outcomes.Entities:
Keywords: Dietary modification; General practice; Indigenous population; Outcome and process assessment; Pragmatic clinical trial; Prediabetes; Primary care nursing; Qualitative evaluation; Structured intervention implementation; Weight loss
Mesh:
Substances:
Year: 2017 PMID: 29268719 PMCID: PMC5740796 DOI: 10.1186/s12875-017-0671-8
Source DB: PubMed Journal: BMC Fam Pract ISSN: 1471-2296 Impact factor: 2.497
Demographic characteristics and glycaemic outcomes for the 20 intervention participants who were interviewed
| Patient participants | Normoglycaemia | Prediabetes | Diabetes | Total |
|---|---|---|---|---|
| Māori female | 4 | 4 | ||
| Māori male | 1 | 3 | 1 | 5 |
| NZ European female | 2 | 2 | 1 | 5 |
| NZ European male | 1 | 3 | 4 | |
| Pacific female | 1 | 1 | ||
| Pacific male | 1 | 1 | ||
| Total | 4 | 14 | 2 | 20 |
Fig. 1Flow of study participants
Demographic characteristics and diabetes-related co-morbidities of participants at baseline and 6-months. Data presented are number (%)
| Control | Intervention | Between groups | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| At baseline ( | With follow-up data ( | No 6-month data ( | Retention | At baseline ( | With follow-up data ( | No 6-month data ( | Retention | At baselinea | At 6-monthsa | ||
|
|
|
|
|
|
| ||||||
|
| |||||||||||
| ≤ 49 | 11 (15) | 11 (17) | 0 (0) | 0.719 | 13 (15) | 8 (12) | 5 (28) | 0.226 | 0.724 | 0.582 | |
| 50–64 | 40 (56) | 36 (55) | 4 (67) | 42 (49) | 35 (52) | 7 (39) | |||||
| ≥ 65 | 21 (29) | 19 (29) | 2 (33) | 30 (35) | 24 (36) | 6 (33) | |||||
|
| |||||||||||
| Female | 28 (39) | 25 (38) | 3 (50) | 0.672 | 46 (54) | 38 (57) | 8 (44) | 0.429 | 0.077 | 0.370 | |
| Male | 44 (61) | 41 (62) | 3 (50) | 39 (46) | 29 (43) | 10 (56) | |||||
|
| |||||||||||
| Māori | 22 (31) | 19 (29) | 3 (50) | 0.471 | 27 (32) | 19 (28) | 8 (44) | 0.001 | 0.456 | 0.942 | |
| NZ European & Other | 48 (67) | 45 (68) | 3 (50) | 52 (61) | 47 (70) | 5 (28) | |||||
| Pacific | 2 (3) | 2 (3) | 0 (0) | 6 (7) | 1 (1) | 5 (28) | |||||
|
| |||||||||||
| Yes | 28 (40) | 27 (42) | 1 (17) | 0.390 | 34 (40) | 24 (36) | 10 (56) | 0.179 | 1.000 | 0.590 | |
| No | 42 (60) | 37 (58) | 5 (83) | 50 (60) | 42 (64) | 8 (44) | |||||
|
| |||||||||||
| Above guidelines | 8 (13) | 8 (14) | 0 (0) | 6 (8) | 5 (9) | 1 (6) | 1.000 | 0.573 | 0.560 | ||
| Within guidelines | 54 (87) | 50 (86) | 4 (100) | 65 (92) | 49 (91) | 16 (94) | |||||
|
| |||||||||||
| Current | 12 (17) | 9 (14) | 3 (50) | 0.147 | 18 (21) | 12 (18) | 6 (33) | 0.340 | 0.193 | 0.336 | |
| Never | 24 (33) | 22 (33) | 2 (33) | 26 (31) | 20 (30) | 6 (33) | |||||
| Past – quit >12 months | 31 (43) | 30 (45) | 1 (17) | 27 (32) | 24 (36) | 3 (17) | |||||
| Past – quit <12 months | 5 (7) | 5 (8) | 0 (0) | 14 (16) | 11 (16) | 3 (17) | |||||
|
| |||||||||||
| Hypertension | |||||||||||
| Yes | 39 (55) | 36 (55) | 3 (50) | 1.000 | 38 (45) | 30 (45) | 8 (44) | 1.000 | 0.260 | 0.296 | |
| No | 32 (45) | 29 (45) | 3 (50) | 47 (55) | 37 (55) | 10 (56) | |||||
| Ischaemic heart disease | |||||||||||
| Yes | 7 (11) | 5 (8) | 2 (40) | 0.086 | 7 (8) | 5 (7) | 2 (11) | 0.639 | 0.778 | 1.000 | |
| No | 58 (89) | 55 (92) | 3 (60) | 77 (92) | 61 (91) | 16 (89) | |||||
| Stroke | |||||||||||
| Yes | 2 (3) | 1 (2) | 1 (25) | 0.122 | 5 (6) | 4 (6) | 1 (6) | 1.000 | 0.699 | 0.367 | |
| No | 62 (97) | 59 (98) | 3 (75) | 78 (94) | 61 (94) | 17 (94) | |||||
| NAFLD | |||||||||||
| Yes | 4 (7) | 4 (7) | 0 (0) | 1.000 | 1 (1) | 1 (2) | 0 (0) | 1.000 | 0.166 | 0.192 | |
| No | 57 (93) | 53 (93) | 4 (100) | 79 (99) | 61 (98) | 18 (100) | |||||
| Gout | |||||||||||
| Yes | 13 (20) | 13 (22) | 0 (0) | 0.574 | 12 (14) | 8 (12) | 4 (22) | 0.271 | 0.378 | 0.158 | |
| No | 51 (80) | 47 (78) | 4 (100) | 73 (86) | 59 (88) | 14 (78) | |||||
aChi-squared test where at least 80% of cells have expected counts 5 or above, Fisher’s Exact test otherwise
Clinical and laboratory measures for participants at baseline and 6 months. Data presented are arithmetic means (SDs) number (%), unless otherwise stated
| Control ( | Intervention ( | Difference in mean changes in intervention group | ||||
|---|---|---|---|---|---|---|
| Baseline | 6 months | Baseline | 6 months | Ratio (95% CI) |
| |
| HbA1c (mmol/mol) | 43.0 (2.2) | 43.8 (6.2) | 43.2 (2.2) | 42.0 (3.6) | 0.96 (0.92, 1.00) | 0.096 |
| Weight (kg)a | 93.7 (15.1) | 94.6 (15.5) | 96.9 (21.5) | 95.6 (23.8) | 0.97 (0.95, 0.98) | < 0.001 |
| BMI (kg/m2)b | 33.0 (6.0) | 33.3 (6.1) | 35.1 (7.4) | 34.5 (8.1) | – | |
| Waist circumference (cm) | 104.0 (17.9) | 106.0 (12.2) | 109.4 (15.2) | 107.7 (16.3) | 0.97 (0.94, 1.00) | 0.101 |
| Systolic blood pressure (mmHg) | 132.7 (17.0) | 135.0 (16.8) | 133.0 (13.7) | 131.2 (13.8) | 0.97 (0.92, 1.05) | 0.422 |
| Diastolic blood pressure (mmHg) | 81.2 (10.9) | 80.3 (10.7) | 79.6 (9.1) | 79.2 (9.2) | 1.00 (0.94, 1.04) | 0.949 |
| Total cholesterol (mmol/l) | 5.3 (1.3) | 5.2 (1.3) | 5.3 (1.4) | 5.2 (1.1) | 1.00 (0.95 1.08) | 0.933 |
| HDL-cholesterol (mmol/l) | 1.2 (0.3) | 1.2 (0.4) | 1.3 (0.5) | 1.3 (0.5) | 1.02 (0.96, 1.09) | 0.595 |
| Triglycerides (mmol/l) | 2.4 (1.8) | 2.4 (1.7) | 2.1 (1.1) | 2.2 (1.3) | 0.95 (0.79, 1.24) | 0.596 |
| Alanine transaminase (IU/L) | 33.7 (20.3) | 33.4 (18.2) | 28.5 (15.2) | 26.0 (12.3) | 0.91 (0.75, 1.03) | 0.206 |
| Aspartate aminotransferase (IU/L) | 25.6 (10.3) | 25.6 (11.3) | 23.9 (7.5) | 22.9 (9.7) | 0.95 (0.73, 1.12) | 0.649 |
| Gamma glutamyl transpeptidase (IU/L)c | 39.0 (31.5) | 41.0 (33.0) | 32.0 (61.0) | 31.0 (53.0) | −4.00 (−8.19, 2.22) | 0.369 |
| Urate (mmol/l) | 0.39 (0.11) | 0.37 (0.09) | 0.36 (0.07) | 0.37 (0.08) | 0.02 (−0.01, 0.25) | 0.799 |
Statistical comparisons are from linear regression models, except for GGT where a quantile regression model was used to model medians, adjusting for baseline values, sex, alcohol consumption, family history of T2DM, and ethnicity and adjusting standard errors for clustering within practices
a6-month weight measurement was missing for one intervention participant. bRatio not analysed as weight was the preferred body mass outcome. cLog-transformed